A carregar...
Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1
Although anti-retroviral therapies have greatly extended the lives of HIV infected individuals, current treatments are unable to completely eliminate virally infected cells. A number of latency reversing agents have been proposed for use in a “shock and kill” strategy to reactivate latent HIV, thus...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6258234/ https://ncbi.nlm.nih.gov/pubmed/30475902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0208055 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|